4 points | by ck2 8 hours ago
1 comments
previous coverage before it was approved, explaining the superiority
* https://www.theatlantic.com/health/archive/2023/10/xocova-en...
* https://nypost.com/2023/10/26/health/why-covid-sufferers-in-...
Differences in Treatment Patterns and Patient Characteristics Between COVID-19 Patients Treated with Nirmatrelvir/Ritonavir and Ensitrelvir in Japan
* https://pmc.ncbi.nlm.nih.gov/articles/PMC11345459/
previous coverage before it was approved, explaining the superiority
* https://www.theatlantic.com/health/archive/2023/10/xocova-en...
* https://nypost.com/2023/10/26/health/why-covid-sufferers-in-...
Differences in Treatment Patterns and Patient Characteristics Between COVID-19 Patients Treated with Nirmatrelvir/Ritonavir and Ensitrelvir in Japan
* https://pmc.ncbi.nlm.nih.gov/articles/PMC11345459/